• New
Cobra Venom Factor activated Normal Human Serum (NB-SR001)
search
  • Cobra Venom Factor activated Normal Human Serum (NB-SR001)

Cobra Venom Factor activated Normal Human Serum

Catalog # NB-SR001

Print

$598.00
Quantity

For research use only. Not for diagnostic or therapeutic use, or for human or veterinary use. Sold only to research institutions and qualified laboratory professionals. Not for sale to individuals for personal use.

Cobra Venom Factor activated Normal Human Serum (catalog number NB-SR001) is a complement research reagent from Novatein Biosciences. Size: 1.0 ml/vial.

Detailed description

Availability: supplied to customers in the USA only.

Handling: human-derived material. Use normal precautions for handling human blood products.

Specifications

  • Concentration: >50 mg/ml (see Certificate of Analysis for exact conc.)
  • Form: Frozen liquid
  • Activity: <10% C3 and C5 activity versus normal human serum standard
  • Buffer: None
  • Preservative: None, 0.22 µm filtered
  • Storage: -70 °C or below. Minimize freeze/thaw cycles.
  • Source: Normal human serum (shown by certified tests to be negative for HBsAg and for antibodies to HCV, HIV-1 and HIV-II).
  • Precautions: Use normal precautions for handling human blood products.

General Description

CVF-NHS is generated by activating the complement system in normal human serum with cobra venom factor (CVF) purified from the venom of Naja naja kaouthia. CVF from Naja naja kaouthia produces an enzyme that cleaves both human C3 and C5. The affinity of the Naja naja kaouthia CVF for C5 is so high that it primarily consumes C5 first, then C3.

Physical Characteristics & Structure

CVF-NHS is serum supplied as a clear, straw-colored liquid containing an activated complement system and hence no complement activity. CVF-NHS also contains CVF used for activating the complement system.

Function

CVF-NHS is tested for C3 and C5 activity by hemolytic assays using antibody- sensitized sheep erythrocytes and C3-depleted human serum or C5-depleted human serum. The assays verify that CVF-NHS has < 10% of C3 and C5 activity or >90% consumption of C3 and C5 activity in CVF-NHS when compared to normal human serum standard.

Assays

See Function

Applications

CVF-NHS is a serum source which lacks complement activity due to its consumption upon activation with CVF.

Precautions/Toxicity/Hazards

The source is human serum, therefore precautions appropriate for handling any blood-derived product must be used even though the source was shown by certified tests to be negative for HBsAg and for antibodies to HCV, HIV-1 and HIV-II.

Hazard Code: B MSDS available upon request.

Download